The University of Chicago Header Logo

Connection

Nishant Agrawal to Ipilimumab

Back to Details
This is a "connection" page, showing publications Nishant Agrawal has written about Ipilimumab.
Nishant Agrawal
Connection Strength
0.051
Ipilimumab
  1. Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab. Mod Pathol. 2022 11; 35(11):1529-1539.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.